GLO Pharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GLO Pharma, Inc. - overview
Established
2018
Location
Carlsbad, CA, US
Primary Industry
Consumer Products
About
Founded in 2018 by Vimla Black Gupta, Lauren Otsuki, and Scott Glenn, and based in California, US, GLO Pharma, Inc. , trading under the name Ourself, offers skincare products developed using intide, a peptide made out of collagen and elastin to restore the skin without needles and lasers. In August 2021, GLO Pharma, Inc. raised USD 22 million in venture funding from First Round Capital and Lightspeed Venture Partners.
The products developed by the company provide solutions for hyperpigmentation, lips, fine lines and wrinkles. The products include lip filler, lip conditioner, dark spot intercept, dark spot peel, brightening peel, daily renewal cream, mineral sunscreen broad spectrum, etc.
Current Investors
Lightspeed Venture Partners, First Round Capital
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.ourself.com
Verticals
E-commerce, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.